Literature DB >> 7976366

[Indosol--a nonsteroidal anti-inflammatory drug with therapeutic efficacy].

L I Kahánné1, J Bögi, A Farkas, F H Tüdös, G Imre.   

Abstract

For the topical employing of nonsteroidal antiinflammatory drugs, some technological problems are to be solved. These were accomplished by the authors by preparing Indosol [indomethacin-TRIS (tromethamine) salt]. pH and osmotic pressure of Indosol eye-drops are similar to that of the tear fluid. The Indosol eye-drops have a great therapeutic efficacy. Indosol eye-drops do not alter tear film break up time (BUT) and do not inhibit reepithelization of the cornea. Indosol eye-drops proved to be useful in the treatment of the anterior segment and the uvea. The most important use is the pre- and post-treatment in intraocular surgery. Indosol eye-drops contribute to the safety of lens-extraction and lens implantation. The great bioavailability was also shown by the high indomethacin level of the aqueous humor after instillation Indosol eye-drops. It does not cause any deleterious side-effects even in long term treatments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976366

Source DB:  PubMed          Journal:  Acta Pharm Hung        ISSN: 0001-6659


  3 in total

1.  Interaction of indomethacin and ciprofloxacin in the cornea following phototherapeutic keratectomy.

Authors:  Nóra Szentmáry; Márta Kraszni; Zoltán Zsolt Nagy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-02       Impact factor: 3.117

2.  Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2016-10-25       Impact factor: 5.571

Review 3.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.